PI3K pathway mutations are highly prevalent in endometrial cancer [33], and the aforementioned gene expression observations were noted in the context of oncogenic PIK3CAH1047R in our genetic mouse models. The gene discussed is PIK3CA; the disease is endometrial cancer.